Fig. 4From: A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezilLeast squares mean change from baseline in NPI score. LS least squares, NPI Neuropsychiatric Inventory, SE standard errorBack to article page